Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
Holders of 5% or more of VOR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vor Biopharma Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 13D/A | 19.90%9.02M shares | +5.90 ppfrom 14.00% | Dec 30, 20249 filings | Mar 16, 2026 | SEC |
| Reprogrammed Interchange LLC | 13D/A | 17.60%1.20M shares | −1.00 ppfrom 18.60% | Jan 7, 20259 filings | Oct 17, 2025 | SEC |
| ForGrowth III PA B.V. | 13D | 9.99%10.2M shares | 0.00 ppfrom 9.99% | Sep 23, 20252 filings | Dec 23, 2025 | SEC |
| Verve Capital Ltd | 13G/A | 9.90%4.30M shares | 0.00 ppfrom 9.90% | Sep 26, 20252 filings | Feb 17, 2026 | SEC |
| Venrock Healthcare Capital Partners III, L.P. | 13G/A | 9.90%2.22M shares | 0.00 ppfrom 9.90% | Sep 25, 20252 filings | Feb 17, 2026 | SEC |
| FMR LLC | 13G/A | 6.50%2.53M shares | −5.00 ppfrom 11.50% | Nov 7, 20252 filings | Feb 5, 2026 | SEC |
| Frazier Life Sciences Public Fund, L.P. | 13G | 5.80%2.26M shares | New | Dec 19, 20251 filing | Dec 19, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
37 Schedule 13D and 13G filings on Vor Biopharma Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 20264:15 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 19.90%9.02M shares | +5.90 ppfrom 14.00% | Mar 12, 2026 | SEC |
| Feb 17, 20266:59 PM ET | Verve Capital Ltd | 13G/A | 9.90%4.30M shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Feb 17, 20266:22 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 9.90%2.22M shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Feb 17, 20264:13 PM ET | Great Point Partners LLCand 2 others | 13G/A | 3.30%1.37M shares | −2.33 ppfrom 5.63%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20264:02 PM ET | Paradigm Biocapital Advisors LPand 3 others | 13G/A | 4.50%1.75M shares | −4.10 ppfrom 8.60%Below 5% | Dec 31, 2025 | SEC |
| Feb 13, 20267:47 PM ET | Qiming Venture Partners VIII-HC, L.P.and 3 others | 13G/A | 2.80%1.09M shares | −2.64 ppfrom 5.44%Below 5% | Dec 31, 2025 | SEC |
| Feb 5, 20261:40 PM ET | FMR LLCand 1 other | 13G/A | 6.50%2.53M shares | −5.00 ppfrom 11.50% | Dec 31, 2025 | SEC |
| Dec 23, 20254:05 PM ET | ForGrowth III PA B.V.and 2 others | 13D | 9.99%10.2M shares | 0.00 ppfrom 9.99% | Dec 18, 2025 | SEC |
| Dec 19, 20254:40 PM ET | Frazier Life Sciences Public Fund, L.P.and 8 others | 13G | 5.80%2.26M shares | New | Dec 18, 2025 | SEC |
| Dec 18, 20256:31 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 14.00%5.41M shares | +4.10 ppfrom 9.90% | Dec 18, 2025 | SEC |
| Dec 17, 20254:00 PM ET | Great Point Partners LLCand 2 others | 13G | 5.63%1.23M shares | New | Dec 10, 2025 | SEC |
| Nov 18, 20254:30 PM ET | Paradigm Biocapital Advisors LPand 3 others | 13G | 8.60%1.75M shares | New | Nov 11, 2025 | SEC |
| Nov 14, 20256:13 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 9.90%2.35M shares | −1.60 ppfrom 11.50% | Nov 12, 2025 | SEC |
| Nov 7, 202511:13 AM ET | FMR LLCand 1 other | 13G | 11.50%788.4K shares | New | Oct 31, 2025 | SEC |
| Nov 5, 20254:14 PM ET | Qiming Venture Partners VIII-HC, L.P.and 3 others | 13G | 5.44%496.3K shares | New | Sep 18, 2025 | SEC |
| Oct 30, 20256:42 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 11.50%810.7K shares | −5.80 ppfrom 17.30% | Oct 28, 2025 | SEC |
| Oct 27, 20258:06 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 17.30%1.19M shares | −3.60 ppfrom 20.90% | Oct 23, 2025 | SEC |
| Oct 20, 20256:58 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 20.90%1.43M shares | −8.10 ppfrom 29.00% | Oct 16, 2025 | SEC |
| Oct 17, 20256:36 PM ET | Reprogrammed Interchange LLCand 1 other | 13D/A | 17.60%1.20M shares | −1.00 ppfrom 18.60% | Oct 15, 2025 | SEC |
| Oct 16, 20254:45 PM ET | Reprogrammed Interchange LLCand 1 other | 13D/A | 18.60%1.28M shares | −1.50 ppfrom 20.10% | Oct 14, 2025 | SEC |
| Oct 10, 20255:52 PM ET | Reprogrammed Interchange LLCand 1 other | 13D/A | 20.10%1.37M shares | −1.80 ppfrom 21.90% | Oct 8, 2025 | SEC |
| Oct 8, 20255:24 PM ET | Reprogrammed Interchange LLCand 1 other | 13D/A | 21.90%1.50M shares | −1.40 ppfrom 23.30% | Oct 6, 2025 | SEC |
| Oct 6, 20255:20 PM ET | Reprogrammed Interchange LLCand 1 other | 13D/A | 23.30%1.60M shares | −3.50 ppfrom 26.80% | Oct 2, 2025 | SEC |
| Sep 26, 20258:18 AM ET | Verve Capital Ltd | 13G | 9.90%760.7K shares | New | Sep 18, 2025 | SEC |
| Sep 25, 20258:34 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G | 9.90%760.7K shares | New | Sep 18, 2025 | SEC |
| Sep 23, 20254:00 PM ET | ForGrowth III PA B.V.and 2 others | 13G | 9.99%7.00M shares | New | Sep 18, 2025 | SEC |
| Sep 19, 20254:53 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 29.00%1.99M shares | −2.80 ppfrom 31.80% | Sep 17, 2025 | SEC |
| Sep 12, 20257:07 PM ET | Reprogrammed Interchange LLCand 1 other | 13D/A | 26.80%33.9M shares | −1.20 ppfrom 28.00% | Sep 11, 2025 | SEC |
| Sep 9, 20256:04 PM ET | Reprogrammed Interchange LLCand 1 other | 13D/A | 28.00%35.5M shares | −1.10 ppfrom 29.10% | Sep 5, 2025 | SEC |
| Aug 29, 20256:30 PM ET | Reprogrammed Interchange LLCand 1 other | 13D/A | 29.10%36.9M shares | −2.20 ppfrom 31.30% | Aug 27, 2025 | SEC |
| Aug 6, 202512:19 PM ET | FMR LLCand 1 other | 13G/A | 1.70%2.09M shares | −3.40 ppfrom 5.10%Below 5% | Jun 30, 2025 | SEC |
| Jul 9, 20255:00 PM ET | 5AM Ventures VI, L.P.and 5 others | 13D/A | 3.50%4.42M shares | –Below 5% | Jul 8, 2025 | SEC |
| Jun 27, 20254:16 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 31.80%39.7M shares | −0.10 ppfrom 31.90% | Jun 25, 2025 | SEC |
| May 12, 202510:20 AM ET | FMR LLCand 1 other | 13G/A | 5.10%6.42M shares | −4.20 ppfrom 9.30% | Mar 31, 2025 | SEC |
| Feb 12, 20259:34 AM ET | FMR LLCand 1 other | 13G/A | 9.30%6.42M shares | – | Dec 31, 2024 | SEC |
| Jan 7, 20254:53 PM ET | Reprogrammed Interchange LLCand 1 other | 13D | 31.30%39.0M shares | New | Dec 30, 2024 | SEC |
| Dec 30, 20246:51 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 31.90%39.7M shares | – | Dec 26, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Vor Biopharma Inc. shares.
No Form 144 notices for Vor Biopharma Inc. are on file.